reference/25574402

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25574402

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	5982
issn	1528-0020 0006-4971
issueIdentifier	26
pageRange	5972-5982
publicationName	Blood
startingPage	5972
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ee4587986d4c489e3175992f71fd5f59 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c7707d630afb025da14004d71a88773e
bibliographicCitation	Wang X, Zhang W, Tripodi J, Lu M, Xu M, Najfeld V, Li Y, Hoffman R. Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells. Blood. 2010 Dec 23;116(26):5972–82. PMID: 20858855; PMCID: PMC3031385.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbf462c8ddb2d78177367bf171b16143 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9baa2d4cfa75eedd34f1c70b237655d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2a0aad185748a11550ef533abe00c34 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16b9eb2b539fc3eef356b5e7fc56b352 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66a0eff99d9e77db324961ba30647a70 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc4391cf53a23cdcb359644b4817e719 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3033-1081 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_207c87914717455fbfd1feb4cec7c787 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b954baf86ee02fa23a94a70f1f89470
date	2010-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1182/blood-2010-02-269696 https://pubmed.ncbi.nlm.nih.gov/PMC3031385 https://pubmed.ncbi.nlm.nih.gov/20858855
isPartOf	https://portal.issn.org/resource/ISSN/1528-0020 https://portal.issn.org/resource/ISSN/0006-4971 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1243
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells
discusses	http://id.nlm.nih.gov/mesh/M0028322 http://id.nlm.nih.gov/mesh/M0288128 http://id.nlm.nih.gov/mesh/M0203030 http://id.nlm.nih.gov/mesh/M0001471 http://id.nlm.nih.gov/mesh/M0062824 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0004370 http://id.nlm.nih.gov/mesh/M0002060 http://id.nlm.nih.gov/mesh/M0378698 http://id.nlm.nih.gov/mesh/M0019167 http://id.nlm.nih.gov/mesh/M0010739 http://id.nlm.nih.gov/mesh/M0473784 http://id.nlm.nih.gov/mesh/M0484433 http://id.nlm.nih.gov/mesh/M0017875 http://id.nlm.nih.gov/mesh/M0059711
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D053614Q000235 http://id.nlm.nih.gov/mesh/D055728Q000188 http://id.nlm.nih.gov/mesh/D001853Q000378 http://id.nlm.nih.gov/mesh/D009154Q000235 http://id.nlm.nih.gov/mesh/D055728Q000235 http://id.nlm.nih.gov/mesh/D018952Q000378 http://id.nlm.nih.gov/mesh/D002843Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D053614Q000037 http://id.nlm.nih.gov/mesh/D002478 http://id.nlm.nih.gov/mesh/D000077337 http://id.nlm.nih.gov/mesh/D055728Q000473 http://id.nlm.nih.gov/mesh/D011500Q000494 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D020133 http://id.nlm.nih.gov/mesh/D000964Q000494 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D053631Q000502 http://id.nlm.nih.gov/mesh/D016688 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018345 http://id.nlm.nih.gov/mesh/D001374Q000494 http://id.nlm.nih.gov/mesh/D001374Q000031 http://id.nlm.nih.gov/mesh/D016513 http://id.nlm.nih.gov/mesh/D000077209 http://id.nlm.nih.gov/mesh/D015151 http://id.nlm.nih.gov/mesh/D053614Q000378 http://id.nlm.nih.gov/mesh/D006412Q000378 http://id.nlm.nih.gov/mesh/D001853Q000187 http://id.nlm.nih.gov/mesh/D006412Q000187 http://id.nlm.nih.gov/mesh/D006877Q000494 http://id.nlm.nih.gov/mesh/D012333Q000235 http://id.nlm.nih.gov/mesh/D051379
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451668 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8153 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9876 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11133 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_54e32599939667ce8030f6c1725ceac0 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID449435 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444732 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3657 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1d2c6279569a5e5473d9efe0530fd802 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e54ed83d8b6f045de7f7d4b206e5f3af

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129552408 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129625394 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129662076 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128725069 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129520807 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245921350

Total number of triples: 97.